Global Point of Care Testing for Infectious Disease Market Size, Status and Forecast 2021-2027

感染症用ポイントオブケア検査の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Point of Care Testing for Infectious Disease Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR4681
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:99
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、感染症用ポイントオブケア検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(免疫学的検査、病原体核酸検査)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・感染症用ポイントオブケア検査の市場動向
・企業の競争状況、市場シェア
・感染症用ポイントオブケア検査の種類別市場規模(免疫学的検査、病原体核酸検査)
・感染症用ポイントオブケア検査の用途別市場規模(病院、診療所、その他)
・感染症用ポイントオブケア検査の北米市場規模2016-2027(アメリカ、カナダ)
・感染症用ポイントオブケア検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・感染症用ポイントオブケア検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・感染症用ポイントオブケア検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・感染症用ポイントオブケア検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Roche、Siemens、Danaher、Becton, Dickinson、Johnson & Johnson、Instrumentation Laboratory、PTS Diagnostics、Quidel、Sekisui Diagnostics、Nova、EKF Diagnostics、AccuBioTech、Trinity Biotech)
・結論

Market Analysis and Insights: Global Point of Care Testing for Infectious Disease Market
The global Point of Care Testing for Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point of Care Testing for Infectious Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point of Care Testing for Infectious Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point of Care Testing for Infectious Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point of Care Testing for Infectious Disease market.

Global Point of Care Testing for Infectious Disease Scope and Market Size
Point of Care Testing for Infectious Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Testing for Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunological Test
Pathogen Nucleic Acid Test

Segment by Application
Hospital
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Roche
Siemens
Danaher
Becton, Dickinson
Johnson & Johnson
Instrumentation Laboratory
PTS Diagnostics
Quidel
Danaher
Becton, Dickinson
EKF Diagnostics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Testing for Infectious Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunological Test
1.2.3 Pathogen Nucleic Acid Test
1.3 Market by Application
1.3.1 Global Point of Care Testing for Infectious Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Point of Care Testing for Infectious Disease Market Perspective (2016-2027)
2.2 Point of Care Testing for Infectious Disease Growth Trends by Regions
2.2.1 Point of Care Testing for Infectious Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Point of Care Testing for Infectious Disease Historic Market Share by Regions (2016-2021)
2.2.3 Point of Care Testing for Infectious Disease Forecasted Market Size by Regions (2022-2027)
2.3 Point of Care Testing for Infectious Disease Industry Dynamic
2.3.1 Point of Care Testing for Infectious Disease Market Trends
2.3.2 Point of Care Testing for Infectious Disease Market Drivers
2.3.3 Point of Care Testing for Infectious Disease Market Challenges
2.3.4 Point of Care Testing for Infectious Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue
3.1.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue (2016-2021)
3.1.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Players (2016-2021)
3.2 Global Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point of Care Testing for Infectious Disease Revenue
3.4 Global Point of Care Testing for Infectious Disease Market Concentration Ratio
3.4.1 Global Point of Care Testing for Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Testing for Infectious Disease Revenue in 2020
3.5 Point of Care Testing for Infectious Disease Key Players Head office and Area Served
3.6 Key Players Point of Care Testing for Infectious Disease Product Solution and Service
3.7 Date of Enter into Point of Care Testing for Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Point of Care Testing for Infectious Disease Breakdown Data by Type
4.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Type (2016-2021)
4.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Type (2022-2027)

5 Point of Care Testing for Infectious Disease Breakdown Data by Application
5.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Application (2016-2021)
5.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Point of Care Testing for Infectious Disease Market Size (2016-2027)
6.2 North America Point of Care Testing for Infectious Disease Market Size by Type
6.2.1 North America Point of Care Testing for Infectious Disease Market Size by Type (2016-2021)
6.2.2 North America Point of Care Testing for Infectious Disease Market Size by Type (2022-2027)
6.2.3 North America Point of Care Testing for Infectious Disease Market Size by Type (2016-2027)
6.3 North America Point of Care Testing for Infectious Disease Market Size by Application
6.3.1 North America Point of Care Testing for Infectious Disease Market Size by Application (2016-2021)
6.3.2 North America Point of Care Testing for Infectious Disease Market Size by Application (2022-2027)
6.3.3 North America Point of Care Testing for Infectious Disease Market Size by Application (2016-2027)
6.4 North America Point of Care Testing for Infectious Disease Market Size by Country
6.4.1 North America Point of Care Testing for Infectious Disease Market Size by Country (2016-2021)
6.4.2 North America Point of Care Testing for Infectious Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Point of Care Testing for Infectious Disease Market Size (2016-2027)
7.2 Europe Point of Care Testing for Infectious Disease Market Size by Type
7.2.1 Europe Point of Care Testing for Infectious Disease Market Size by Type (2016-2021)
7.2.2 Europe Point of Care Testing for Infectious Disease Market Size by Type (2022-2027)
7.2.3 Europe Point of Care Testing for Infectious Disease Market Size by Type (2016-2027)
7.3 Europe Point of Care Testing for Infectious Disease Market Size by Application
7.3.1 Europe Point of Care Testing for Infectious Disease Market Size by Application (2016-2021)
7.3.2 Europe Point of Care Testing for Infectious Disease Market Size by Application (2022-2027)
7.3.3 Europe Point of Care Testing for Infectious Disease Market Size by Application (2016-2027)
7.4 Europe Point of Care Testing for Infectious Disease Market Size by Country
7.4.1 Europe Point of Care Testing for Infectious Disease Market Size by Country (2016-2021)
7.4.2 Europe Point of Care Testing for Infectious Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Point of Care Testing for Infectious Disease Market Size (2016-2027)
8.2 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Type
8.2.1 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Application
8.3.1 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region
8.4.1 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Point of Care Testing for Infectious Disease Market Size (2016-2027)
9.2 Latin America Point of Care Testing for Infectious Disease Market Size by Type
9.2.1 Latin America Point of Care Testing for Infectious Disease Market Size by Type (2016-2021)
9.2.2 Latin America Point of Care Testing for Infectious Disease Market Size by Type (2022-2027)
9.2.3 Latin America Point of Care Testing for Infectious Disease Market Size by Type (2016-2027)
9.3 Latin America Point of Care Testing for Infectious Disease Market Size by Application
9.3.1 Latin America Point of Care Testing for Infectious Disease Market Size by Application (2016-2021)
9.3.2 Latin America Point of Care Testing for Infectious Disease Market Size by Application (2022-2027)
9.3.3 Latin America Point of Care Testing for Infectious Disease Market Size by Application (2016-2027)
9.4 Latin America Point of Care Testing for Infectious Disease Market Size by Country
9.4.1 Latin America Point of Care Testing for Infectious Disease Market Size by Country (2016-2021)
9.4.2 Latin America Point of Care Testing for Infectious Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Point of Care Testing for Infectious Disease Market Size (2016-2027)
10.2 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Type
10.2.1 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Application
10.3.1 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country
10.4.1 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point of Care Testing for Infectious Disease Introduction
11.1.4 Abbott Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Point of Care Testing for Infectious Disease Introduction
11.2.4 Roche Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Point of Care Testing for Infectious Disease Introduction
11.3.4 Siemens Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.3.5 Siemens Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Point of Care Testing for Infectious Disease Introduction
11.4.4 Danaher Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.4.5 Danaher Recent Development
11.5 Becton, Dickinson
11.5.1 Becton, Dickinson Company Details
11.5.2 Becton, Dickinson Business Overview
11.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Introduction
11.5.4 Becton, Dickinson Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.5.5 Becton, Dickinson Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Introduction
11.6.4 Johnson & Johnson Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Instrumentation Laboratory
11.7.1 Instrumentation Laboratory Company Details
11.7.2 Instrumentation Laboratory Business Overview
11.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Introduction
11.7.4 Instrumentation Laboratory Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.7.5 Instrumentation Laboratory Recent Development
11.8 PTS Diagnostics
11.8.1 PTS Diagnostics Company Details
11.8.2 PTS Diagnostics Business Overview
11.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Introduction
11.8.4 PTS Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.8.5 PTS Diagnostics Recent Development
11.9 Quidel
11.9.1 Quidel Company Details
11.9.2 Quidel Business Overview
11.9.3 Quidel Point of Care Testing for Infectious Disease Introduction
11.9.4 Quidel Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.9.5 Quidel Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Introduction
11.10.4 Sekisui Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Nova
11.11.1 Nova Company Details
11.11.2 Nova Business Overview
11.11.3 Nova Point of Care Testing for Infectious Disease Introduction
11.11.4 Nova Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.11.5 Nova Recent Development
11.12 EKF Diagnostics
11.12.1 EKF Diagnostics Company Details
11.12.2 EKF Diagnostics Business Overview
11.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Introduction
11.12.4 EKF Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.12.5 EKF Diagnostics Recent Development
11.13 AccuBioTech
11.13.1 AccuBioTech Company Details
11.13.2 AccuBioTech Business Overview
11.13.3 AccuBioTech Point of Care Testing for Infectious Disease Introduction
11.13.4 AccuBioTech Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.13.5 AccuBioTech Recent Development
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Details
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Introduction
11.14.4 Trinity Biotech Revenue in Point of Care Testing for Infectious Disease Business (2016-2021)
11.14.5 Trinity Biotech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Point of Care Testing for Infectious Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunological Test
Table 3. Key Players of Pathogen Nucleic Acid Test
Table 4. Global Point of Care Testing for Infectious Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Point of Care Testing for Infectious Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Point of Care Testing for Infectious Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Point of Care Testing for Infectious Disease Market Share by Regions (2016-2021)
Table 8. Global Point of Care Testing for Infectious Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Point of Care Testing for Infectious Disease Market Share by Regions (2022-2027)
Table 10. Point of Care Testing for Infectious Disease Market Trends
Table 11. Point of Care Testing for Infectious Disease Market Drivers
Table 12. Point of Care Testing for Infectious Disease Market Challenges
Table 13. Point of Care Testing for Infectious Disease Market Restraints
Table 14. Global Point of Care Testing for Infectious Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Point of Care Testing for Infectious Disease Market Share by Players (2016-2021)
Table 16. Global Top Point of Care Testing for Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Testing for Infectious Disease as of 2020)
Table 17. Ranking of Global Top Point of Care Testing for Infectious Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Point of Care Testing for Infectious Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Point of Care Testing for Infectious Disease Product Solution and Service
Table 21. Date of Enter into Point of Care Testing for Infectious Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Point of Care Testing for Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Point of Care Testing for Infectious Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Point of Care Testing for Infectious Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Point of Care Testing for Infectious Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Point of Care Testing for Infectious Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Point of Care Testing for Infectious Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Point of Care Testing for Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Point of Care Testing for Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Point of Care Testing for Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Point of Care Testing for Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Point of Care Testing for Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Point of Care Testing for Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Point of Care Testing for Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Point of Care Testing for Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Point of Care Testing for Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Point of Care Testing for Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Point of Care Testing for Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Point of Care Testing for Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Point of Care Testing for Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Point of Care Testing for Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Point of Care Testing for Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Point of Care Testing for Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Point of Care Testing for Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Point of Care Testing for Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Point of Care Testing for Infectious Disease Product
Table 64. Abbott Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Point of Care Testing for Infectious Disease Product
Table 69. Roche Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Siemens Company Details
Table 72. Siemens Business Overview
Table 73. Siemens Point of Care Testing for Infectious Disease Product
Table 74. Siemens Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 75. Siemens Recent Development
Table 76. Danaher Company Details
Table 77. Danaher Business Overview
Table 78. Danaher Point of Care Testing for Infectious Disease Product
Table 79. Danaher Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 80. Danaher Recent Development
Table 81. Becton, Dickinson Company Details
Table 82. Becton, Dickinson Business Overview
Table 83. Becton, Dickinson Point of Care Testing for Infectious Disease Product
Table 84. Becton, Dickinson Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 85. Becton, Dickinson Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Point of Care Testing for Infectious Disease Product
Table 89. Johnson & Johnson Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Instrumentation Laboratory Company Details
Table 92. Instrumentation Laboratory Business Overview
Table 93. Instrumentation Laboratory Point of Care Testing for Infectious Disease Product
Table 94. Instrumentation Laboratory Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 95. Instrumentation Laboratory Recent Development
Table 96. PTS Diagnostics Company Details
Table 97. PTS Diagnostics Business Overview
Table 98. PTS Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 99. PTS Diagnostics Recent Development
Table 100. Quidel Company Details
Table 101. Quidel Business Overview
Table 102. Quidel Point of Care Testing for Infectious Disease Product
Table 103. Quidel Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 104. Quidel Recent Development
Table 105. Sekisui Diagnostics Company Details
Table 106. Sekisui Diagnostics Business Overview
Table 107. Sekisui Diagnostics Point of Care Testing for Infectious Disease Product
Table 108. Sekisui Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 109. Sekisui Diagnostics Recent Development
Table 110. Nova Company Details
Table 111. Nova Business Overview
Table 112. Nova Point of Care Testing for Infectious Disease Product
Table 113. Nova Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 114. Nova Recent Development
Table 115. EKF Diagnostics Company Details
Table 116. EKF Diagnostics Business Overview
Table 117. EKF Diagnostics Point of Care Testing for Infectious Disease Product
Table 118. EKF Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 119. EKF Diagnostics Recent Development
Table 120. AccuBioTech Company Details
Table 121. AccuBioTech Business Overview
Table 122. AccuBioTech Point of Care Testing for Infectious Disease Product
Table 123. AccuBioTech Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 124. AccuBioTech Recent Development
Table 125. Trinity Biotech Company Details
Table 126. Trinity Biotech Business Overview
Table 127. Trinity Biotech Point of Care Testing for Infectious Disease Product
Table 128. Trinity Biotech Revenue in Point of Care Testing for Infectious Disease Business (2016-2021) & (US$ Million)
Table 129. Trinity Biotech Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Testing for Infectious Disease Market Share by Type: 2020 VS 2027
Figure 2. Immunological Test Features
Figure 3. Pathogen Nucleic Acid Test Features
Figure 4. Global Point of Care Testing for Infectious Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Point of Care Testing for Infectious Disease Report Years Considered
Figure 9. Global Point of Care Testing for Infectious Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Point of Care Testing for Infectious Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Point of Care Testing for Infectious Disease Market Share by Regions: 2020 VS 2027
Figure 12. Global Point of Care Testing for Infectious Disease Market Share by Regions (2022-2027)
Figure 13. Global Point of Care Testing for Infectious Disease Market Share by Players in 2020
Figure 14. Global Top Point of Care Testing for Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Testing for Infectious Disease as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Point of Care Testing for Infectious Disease Revenue in 2020
Figure 16. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type (2016-2021)
Figure 17. Global Point of Care Testing for Infectious Disease Revenue Market Share by Type (2022-2027)
Figure 18. North America Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Point of Care Testing for Infectious Disease Market Share by Type (2016-2027)
Figure 20. North America Point of Care Testing for Infectious Disease Market Share by Application (2016-2027)
Figure 21. North America Point of Care Testing for Infectious Disease Market Share by Country (2016-2027)
Figure 22. United States Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Point of Care Testing for Infectious Disease Market Share by Type (2016-2027)
Figure 26. Europe Point of Care Testing for Infectious Disease Market Share by Application (2016-2027)
Figure 27. Europe Point of Care Testing for Infectious Disease Market Share by Country (2016-2027)
Figure 28. Germany Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Point of Care Testing for Infectious Disease Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Point of Care Testing for Infectious Disease Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Point of Care Testing for Infectious Disease Market Share by Region (2016-2027)
Figure 38. China Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Point of Care Testing for Infectious Disease Market Share by Type (2016-2027)
Figure 46. Latin America Point of Care Testing for Infectious Disease Market Share by Application (2016-2027)
Figure 47. Latin America Point of Care Testing for Infectious Disease Market Share by Country (2016-2027)
Figure 48. Mexico Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Point of Care Testing for Infectious Disease Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Point of Care Testing for Infectious Disease Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Point of Care Testing for Infectious Disease Market Share by Country (2016-2027)
Figure 54. Turkey Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Point of Care Testing for Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 59. Siemens Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 60. Danaher Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 61. Becton, Dickinson Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 63. Instrumentation Laboratory Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 64. PTS Diagnostics Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 65. Quidel Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 66. Sekisui Diagnostics Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 67. Nova Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 68. EKF Diagnostics Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 69. AccuBioTech Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 70. Trinity Biotech Revenue Growth Rate in Point of Care Testing for Infectious Disease Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[感染症用ポイントオブケア検査の世界市場規模・現状・予測2021年-2027年] (Global Point of Care Testing for Infectious Disease Market Size, Status and Forecast 2021-2027 / QY21APR4681)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆